Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001967167 | SCV002200666 | benign | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003167318 | SCV003883933 | uncertain significance | Inborn genetic diseases | 2023-03-06 | criteria provided, single submitter | clinical testing | The c.4389G>C (p.Q1463H) alteration is located in exon 6 (coding exon 5) of the SETBP1 gene. This alteration results from a G to C substitution at nucleotide position 4389, causing the glutamine (Q) at amino acid position 1463 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004538638 | SCV004118922 | uncertain significance | SETBP1-related disorder | 2023-05-12 | criteria provided, single submitter | clinical testing | The SETBP1 c.4389G>C variant is predicted to result in the amino acid substitution p.Gln1463His. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |